Soluble CD40 ligand and endothelial dysfunction in aspirin-treated polycythaemia vera patients

British Journal of Haematology

Volumn 145, Issue 4, 2009, Pages 538-540

  Lessiani, Gianfranco ^a   Dragani, Alfredo ^b   Falco, Angela ^a   Fioritoni, Francesca ^b   Santilli, Francesca ^a   Davì, Giovanni ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b Pescara Hospital   (Italy)

Author keywords

Aspirin; CD40L; Endothelial dysfunction; Polycythaemia vera; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CD40 LIGAND; HYDROXYUREA; NITRIC OXIDE;

ADULT; AGED; BRACHIAL ANGIOGRAPHY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEEP VEIN THROMBOSIS; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW MEASUREMENT; HEART INFARCTION; HUMAN; HYPERTENSION; INFORMED CONSENT; LETTER; MALE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SUPERFICIAL THROMBOPHLEBITIS; THROMBOCYTE ACTIVATION; THROMBOCYTHEMIA; TRANSIENT ISCHEMIC ATTACK; UPREGULATION;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; CD40 LIGAND; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; POLYCYTHEMIA VERA; STATISTICS, NONPARAMETRIC; VASODILATION;

EID: 65349193834     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07636.x     Document Type: Letter

References (10)

1. Ferroni, P., Santilli, F., Guadagni, F., Basili, S. Davì, G. (2007) Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis. Current Medicinal Chemistry, 14, 2170 2180. (Pubitemid 47591314)
2. Gruppo Italiano Studio Policitemia Polycythaemia vera 1995) The natural history of 1213 patients followed for 20 years. Annals of Internal Medicine, 123, 656 664.
3. Henn, V., Slupsky, J.R., Grafe, M., Anagnostopoulos, I., Forster, R., Muller-Berghaus, G. Kroczek, R.A. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 391, 591 594. (Pubitemid 28157601)
4. Landolfi, R., Ciabattoni, G., Patrignani, P., Castellana, M.A., Pogliani, E., Bizzi, B. Patrono, C. (1992) Increased thromboxane biosynthesis in patients with polycythaemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood, 80, 1965 1971.
5. Landolfi, R., Marchioli, R., Kutti, J., Gisslinger, H., Tognoni, G., Patrono, C. Barbui, T. (2004) European collaboration on low-dose aspirin in polycythaemia vera investigators. Efficacy and safety of low-dose aspirin in polycythaemia vera. New England Journal of Medicine, 350, 114 124.
6. Michiels, J.J. Juvonen, E. (1997) Proposal for revised diagnostic criteria of essential thrombocythaemia and polycythaemia vera by the thrombocythaemia vera study group. Seminars in Thrombosis and Haemostasis, 23, 339 347. (Pubitemid 27360074)
7. Neunteufl, T., Heher, S., Stefenelli, T., Pabinger, I. Gisslinger, H. (2001) Endothelial dysfunction in patients with polycythaemia vera. British Journal of Haematology, 115, 354 359. (Pubitemid 34203502)
8. Santilli, F., Romano, M., Recchiuti, A., Dragani, A., Falco, A., Lessiani, G., Fioritoni, F., Lattanzio, S., Mattoscio, D., De Cristofaro, R., Rocca, B. Davì, G. (2008) Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythaemia vera patients. Blood, 112, 1085 1090.
9. Schäfer, A., Alp, N.J., Cai, S., Lygate, C.A., Neubauer, S., Eigenthaler, M., Bauersachs, J. Channon, K.M. (2004) Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 1720 1726. (Pubitemid 39180901)
10. Viallard, J.F., Solanilla, A., Gauthier, B., Contin, C., Dechanet, J., Grosset, C., Moreau, J.F., Praloran, V., Nurden, P., Pellegrin, J.L., Nurden, A.T. Ripoche, J. (2002) Increased soluble and platelet-associated CD40L in essential thrombocythaemia and reactive thrombocytosis. Blood, 99, 2612 2614. (Pubitemid 34525455)